AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.09
+0.08 (1.60%)
Sep 29, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $192.08 million as of September 29, 2026. Its market cap has increased by 462.33% in one year.
Market Cap
192.08M
Enterprise Value
113.69M
1-Year Change
462.33%
Ranking
Category
Stock Price
$5.09
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $192.08M, a decrease of -31.67%. That is a compound annual growth rate of -8.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 192.08M | 514.88% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 205.37M |
| Eledon Pharmaceuticals | 204.98M |
| Compass Therapeutics | 200.80M |
| Oramed Pharmaceuticals | 195.30M |
| Canton Strategic Holdings | 192.83M |
| Protara Therapeutics | 191.17M |
| Alpha Cognition | 189.25M |
| Nkarta | 188.02M |